Log in

Advances in the Use of Tocols as Drug Delivery Vehicles

  • Expert Review
  • Published:
Pharmaceutical Research Aims and scope Submit manuscript

Abstract

There has been increasing interest in recent years in the drug delivery applications of tocols and their derivatives. Their biocompatibility and potential to deliver both poorly soluble and water-soluble drugs make tocols attractive as drug delivery vehicles. This review article will focus primarily on topical, oral, and parenteral drug administration using tocols, although other routes of delivery such as pulmonary and nasal will also be discussed. After an overview of the tocol structures, physicochemical properties with emphasis on their solvent properties, functions, and metabolism, specific case studies will be discussed where tocols have been successfully used in topical, oral, and parenteral drug formulations and marketed drug products. Case studies will be extended to those where tocol-based formulations were administered pulmonarily and nasally. As more clinical data and marketed drug products emerge, the utility and therapeutic value of tocols will certainly increase.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Subscribe and save

Springer+ Basic
EUR 32.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or Ebook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Price includes VAT (France)

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6

Similar content being viewed by others

References

  1. P. B. Nielsen. Tocopherol as an oral drug delivery system. Ph.D. thesis, The Royal Danish School of Pharmacy, 2000.

  2. J. Han. The formulation and evaluation of intravenous vitamin E emulsions for the delivery of paclitaxel. Ph.D. thesis, University of Nottingham, 2000.

  3. P. P. Constantinides A. Tustian D. R. Kessler (2004) ArticleTitleTocol emulsions for drug solubilization and parenteral delivery Adv. Drug Deliv. Rev. 56 1243–1255 Occurrence Handle1:CAS:528:DC%2BD2cXjtl2ktrs%3D Occurrence Handle15109767

    CAS  PubMed  Google Scholar 

  4. A. M. Papas (Eds) (1998) Antioxidant Status, Diet, Nutrition and Health CRC Press Boca Raton, FL

    Google Scholar 

  5. M. P. Lupo (2001) ArticleTitleAntioxidants and vitamins in cosmetics Clin. Dermatol. 19 467–473 Occurrence Handle1:STN:280:DC%2BD3Mvpt12nsA%3D%3D Occurrence Handle11535390

    CAS  PubMed  Google Scholar 

  6. L. Packer J. Fuchs (Eds) (1993) Vitamin E in Health and Disease Marcel Dekker New York

    Google Scholar 

  7. B. C. E. Herrera (2001) ArticleTitleVitamin E: action, metabolism and perspectives J. Physiol. Biochem. 57 43–56 Occurrence Handle1:CAS:528:DC%2BD3MXnt1Wgsb8%3D

    CAS  Google Scholar 

  8. S. H.-W. Wu W. K. Hopkins (1999) ArticleTitleCharacteristics of d-α-tocopheryl PEG 1000 succinate for applications as an absorption enhancer in drug delivery systems Pharm. Technol. 23 52–68 Occurrence Handle1:CAS:528:DyaK1MXntlCgsLg%3D

    CAS  Google Scholar 

  9. M. Lahmann T. Thiem (1997) ArticleTitleSynthesis of alpha-tocopheryl oligosaccharides Carbohydr. Res. 299 23–31 Occurrence Handle10.1016/S0008-6215(96)00331-X Occurrence Handle1:CAS:528:DyaK2s**s1Wgurk%3D Occurrence Handle9129294

    Article  CAS  PubMed  Google Scholar 

  10. M. Sikorska H. B. Borowski B. Zurakowski P. R. Walker (2003) ArticleTitleDerivatised alpha-tocopherol as a CoQ10 carrier in a novel water-soluble formulation BioFactors 18 173–183 Occurrence Handle1:CAS:528:DC%2BD3sXpsFenu7g%3D Occurrence Handle14695933

    CAS  PubMed  Google Scholar 

  11. K. A. Lawson K. Anderson M. Menchaca J. Atkinson L. Sun V. Knight B. E. Gilbert C. Conti B. G. Sanders K. Kline (2003) ArticleTitleNovel vitamin E analogue decreases syngeneic mouse mammary tumor burden and reduces lung metastasis Mol. Cancer Ther. 5 437–444

    Google Scholar 

  12. Y. Yi J. H. Kim H.-W. Kang H. S. Oh S. W. Kim M. H. Seo (2005) ArticleTitleA polymeric nanoparticle consisting of mPEG-PLA-Toco and PLMA-COONa as a drug carrier: improvement in cellular uptake and biodistribution Pharm. Res. 22 200–208 Occurrence Handle10.1007/s11095-004-1187-1 Occurrence Handle1:CAS:528:DC%2BD2M**tlCltrY%3D Occurrence Handle15783067

    Article  CAS  PubMed  Google Scholar 

  13. J. C. Bieri L. Corash V. S. Hubbard (1983) ArticleTitleMedical uses of vitamin E N. Engl. J. Med. 308 1063–1071 Occurrence Handle1:STN:280:BiyC28jjsFw%3D Occurrence Handle6339932

    CAS  PubMed  Google Scholar 

  14. A. Kamal-Eldin L. A. Appelqvist (1996) ArticleTitleThe chemistry and antioxidant properties of tocopherols and tocotrienols Lipids 31 671–701 Occurrence Handle1:CAS:528:DyaK28XktlKkt74%3D Occurrence Handle8827691

    CAS  PubMed  Google Scholar 

  15. V. M. D. Mambro A. E. C. S. Azzolini Y. M. L. Valim M. J. V. Fonesca (2003) ArticleTitleComparison of antioxidant activities of tocopherols alone and in pharmaceutical formulations Int. J. Pharm. 262 93–99 Occurrence Handle10.1016/S0378-5173(03)00333-8 Occurrence Handle12927391

    Article  PubMed  Google Scholar 

  16. S. S. Legha Y. M. Wang B. Mackay M. Ewer G. N. Hortobagyi R. S. Benjamin M. K. Ali (1982) ArticleTitleClinical and pharmacologic investigation of the effects of alpha-tocopherol on Adriamycin cardiotoxicity Ann. N.Y. Acad. Sci. 393 411–418 Occurrence Handle1:STN:280:BiyD2szgvFc%3D Occurrence Handle6959564

    CAS  PubMed  Google Scholar 

  17. P. Grammas L. Hamdheydari E. J. Benaskas S. Mou O. N. Pye W. J. Wechter R. A. Floyd C. Stewart K. Hensley (2004) ArticleTitleAnti-inflammatory effects of tocopherol metabolites Biochem. Biophys. Res. Commun. 319 1047–1052 Occurrence Handle10.1016/j.bbrc.2004.05.082 Occurrence Handle1:CAS:528:DC%2BD2cXkslWmsbs%3D Occurrence Handle15184087

    Article  CAS  PubMed  Google Scholar 

  18. J. M. Zingg A. Azzi (2004) ArticleTitleNon-antioxidant activities of vitamin E Curr. Med. Chem. 11 1113–1133 Occurrence Handle1:CAS:528:DC%2BD2cXjvVehtL4%3D Occurrence Handle15134510

    CAS  PubMed  Google Scholar 

  19. D. Li T. Saldeen F. Romeo J. L. Mehta (1999) ArticleTitleRelative effects of alpha- and gamma-tocopherol on low-density lipoprotein oxidation and superoxide dismutase and nitric oxide synthase activity and protein expression in rats Cardiovasc. Pharmacol. Ther. 4 219–226 Occurrence Handle1:CAS:528:DyaK1MXnsFSgtbk%3D

    CAS  Google Scholar 

  20. R. V. Coney A. A. Franke P. J. Harwood V. Hatch-Pigott L. J. Custer L. J Mordan (1993) ArticleTitleGamma-tocopherol detoxification of nitrogen dioxide: superiority to alpha-tocopherol Proc. Natl. Acad. Sci. U. S. A. 90 1771–1775

    Google Scholar 

  21. W. J Wechter D. Kantoci E. D Murray D. C. D'Amico M. E. Jung W. H. Wang (1996) ArticleTitleA new endogenous natriuretic factor: LLU-alpha Proc. Natl. Acad. Sci. U. S. A. 93 6002–6007 Occurrence Handle10.1073/pnas.93.12.6002 Occurrence Handle1:CAS:528:DyaK28Xjs1Ojsb0%3D Occurrence Handle8650209

    Article  CAS  PubMed  Google Scholar 

  22. H. T. Khor D. Y. Chieng K. K. Ong (1995) ArticleTitleTocotrienols inhibit liver HMG-CoA reductase activity in the guinea pig Nutr. Res. 15 537–544 Occurrence Handle10.1016/0271-5317(95)00021-6 Occurrence Handle1:CAS:528:DyaK2MXltFCmsrY%3D

    Article  CAS  Google Scholar 

  23. W. Yu M. Simmons-Menchaca A. Gapor B. G. Sanders K. Kline (1999) ArticleTitleInduction of apoptosis in human breast cancer cells by tocopherols and tocotrienols Nutr. Cancer 33 26–32 Occurrence Handle10227040

    PubMed  Google Scholar 

  24. H. Mo C. E. Elson (1999) ArticleTitleApoptosis and cell-cycle arrest in human and murine tumor cells are initiated by isoprenoids J. Nutr. 129 804–813 Occurrence Handle1:CAS:528:DyaK1M**t12nsLg%3D Occurrence Handle10203554

    CAS  PubMed  Google Scholar 

  25. A. Bendich L. J. Machlin (1993) The safety of oral intake of vitamin E: data from clinical studies from 1986–1991 L. Packer J. Fuchs (Eds) Vitamin E in Health and Disease Marcel Dekker New York 411–416

    Google Scholar 

  26. A. Bjørneboe G.-E. Bjørneboe E. Bodd B. F. Hagen N. Kveseth C. A. Drevon (1986) ArticleTitleTransport and distribution of α-tocopherol in lymph, serum and liver cells in rat Biochim. Biophys. Acta 889 310–315 Occurrence Handle3790578

    PubMed  Google Scholar 

  27. A. Bjørneboe G.-E. Bjørneboe C. A. Drevon (1990) ArticleTitleAbsorption, transport and distribution of vitamin E J. Nutr. 120 233–242 Occurrence Handle2181082

    PubMed  Google Scholar 

  28. P. B. Nielsen A. Mullertz T. Norling H. G. Kristensen (2001) ArticleTitleComparison of the lymphatic transport of a lipophilic drug from vesicles containing alpha-tocopherol and/or triglycerides in rats J. Pharm. Pharmacol. 53 1439–1445 Occurrence Handle10.1211/0022357011777972 Occurrence Handle1:CAS:528:DC%2BD3MXpt1Shu7Y%3D Occurrence Handle11732746

    Article  CAS  PubMed  Google Scholar 

  29. A. Aslam S. A. Misbah K. Talbot H. Chapel (2004) ArticleTitleVitamin E deficiency induced neurological disease in common variable immunodeficiency: two cases and a review of the literature of vitamin E deficiency Clin. Immunol. 112 24–29 Occurrence Handle10.1016/j.clim.2004.02.001 Occurrence Handle1:CAS:528:DC%2BD2cXltVOju7Y%3D Occurrence Handle15207778

    Article  CAS  PubMed  Google Scholar 

  30. R. J. Sokol (1994) ArticleTitleFat-soluble vitamins and their importance in patients with cholestatic liver diseases Gastroenterol. Clin. North Am. 23 673–705 Occurrence Handle1:STN:280:ByqB3MzhtVY%3D Occurrence Handle7698827

    CAS  PubMed  Google Scholar 

  31. M. Schulz M. Leist M. Petrzika B. Gassmann R. Brigelius-Flohe (1995) ArticleTitleNovel urinary metabolite of alpha tocopherol, 2,5,7,8-tetramethyl-2 (2′-carboxyethyl)-6-hydroxychroman, as an indicator of adequate vitamin E supply Am. J. Clin. Nutr. 62 1527–1534

    Google Scholar 

  32. K. Hensley E. J. Benaksas R. Bolli P. Comp P. Grammas L. Hamdheydari S. Mou Q. N. Pye M. F. Stoddard G. Wallis K. S. Williamson M. West W. J. Wechter R. A. Floyd (2004) ArticleTitleNew perspectives on vitamin E: gamma-tocopherol and carboxyethylhydroxychroman metabolites in biology and medicine Free Radic. Biol. Med. 36 1–15 Occurrence Handle10.1016/j.freeradbiomed.2003.10.009 Occurrence Handle1:CAS:528:DC%2BD2cXjsFWgsA%3D%3D Occurrence Handle14732286

    Article  CAS  PubMed  Google Scholar 

  33. M. Traber H. Arai (1999) ArticleTitleMolecular mechanisms of vitamin E transport Annu. Rev. Nutr. 19 343–355 Occurrence Handle10.1146/annurev.nutr.19.1.343 Occurrence Handle1:CAS:528:DyaK1MXlt1ejsLk%3D Occurrence Handle10448528

    Article  CAS  PubMed  Google Scholar 

  34. L. Helson (1984) A Phase I study of vitamin E and neuroblastoma Prasad (Eds) Vitamins, Nutrition and Cancer Karger Basel 274–281

    Google Scholar 

  35. P. B. Nielsen A. Mullertz T. Norling H. G. Kristensen (2001) ArticleTitleThe effect of alpha-tocopherol on the in vitro solubilization of lipophilic drugs Int. J. Pharm. 222 217–224 Occurrence Handle10.1016/S0378-5173(01)00701-3 Occurrence Handle1:CAS:528:DC%2BD3MXks1Wqsr0%3D Occurrence Handle11427352

    Article  CAS  PubMed  Google Scholar 

  36. L. Illum, C. Washington, S. Lawrence, and P. Watts. Lipid vehicle drug delivery composition containing vitamin E, WO 97/03651 Patent, 1997.

  37. M. Francois E. Snoeck P. Putteman F. Wouters E. E. Proost U. Delaet J. Peeters M. E. Brewster (2003) ArticleTitleA mucoadhesive, cyclodextrin-based vaginal cream formulation of itraconazole AAPS PharmSci. 5 1–5 Occurrence Handle10.1208/ps050105

    Article  Google Scholar 

  38. H. M. Aliabadi A. Mahmud A. D. Sharifabadi A. Lavasanifar (2005) ArticleTitleMicelles of methoxy poly(ethylene oxide)-b-poly(ɛ-caprolactone) as vehicles for the solubilization and controlled delivery of cyclosporine A J. Control. Release 104 301–311 Occurrence Handle1:CAS:528:DC%2BD2MXkt1agsr4%3D Occurrence Handle15907581

    CAS  PubMed  Google Scholar 

  39. M. J. O'Neil A. Smith P. E. Heckelman (Eds) (2001) The Merck Index: An Encyclopedia of Chemicals, Drugs and Biologicals EditionNumber13th edn. Merck Whitehouse Station, NJ

    Google Scholar 

  40. R. Liu J. B. Cannon Y. Li (2000) Liposomes in solubilization R. Liu (Eds) Water-Insoluble Drug Formulation Interpharm Press Denver, CO 390–391

    Google Scholar 

  41. P. P. Constantinides, K. J. Lambert, A. K. Tustian, and A. M. Nienstedt. Compositions of tocol-soluble therapeutics, US Patent 6, 479, 540 2002.

    Google Scholar 

  42. USP 23/NF18, Supplement No 9. Tocophersolan, 1998, p. 4712.

  43. E. S. Krol K. A. K-Stickland D. C. Liebler (2000) ArticleTitlePhotoprotective actions of topically applied vitamin E Drug Metab. Rev. 32 413–420 Occurrence Handle10.1081/DMR-100102343 Occurrence Handle1:CAS:528:DC%2BD3MXjsFCmtA%3D%3D Occurrence Handle11139138

    Article  CAS  PubMed  Google Scholar 

  44. M. Ehrlich H. Travel T. Hunt (1972) ArticleTitleInhibitory effects of vitamin E in collagen synthesis and wound repair Ann. Surg. 175 235–240 Occurrence Handle1:CAS:528:DyaE38XktFCjurk%3D Occurrence Handle5059607

    CAS  PubMed  Google Scholar 

  45. M. Kamimara (1972) ArticleTitleAnti-inflammatory activity of vitamin E J. Vitaminol. 18 201–209

    Google Scholar 

  46. M. Rangarajan J. L. Zatz (2003) ArticleTitleEffect of formulation on the topical delivery of α-tocopherol J. Cosmet. Sci. 54 161–174 Occurrence Handle1:CAS:528:DC%2BD3sXnt1Ghsrk%3D Occurrence Handle12715093

    CAS  PubMed  Google Scholar 

  47. G. Cevc (2004) ArticleTitleLipid vehicles and other colloids as drug carriers on the skin Adv. Drug Deliv. Rev. 56 675–711 Occurrence Handle10.1016/j.addr.2003.10.028 Occurrence Handle1:CAS:528:DC%2BD2cXhvFWqsbk%3D Occurrence Handle15019752

    Article  CAS  PubMed  Google Scholar 

  48. M. R. Prausnitz S. Mitragotri R. Langer (2004) ArticleTitleCurrent status and future potential of transdermal drug delivery Nat. Rev., Drug Discov. 3 115–124 Occurrence Handle10.1038/nrd1304 Occurrence Handle1:CAS:528:DC%2BD2cXhtlartbg%3D

    Article  CAS  Google Scholar 

  49. R. Santana and A. Cristiano. Diclofenac pharmaceutical compositions based on vitamin E, papain and hyaluronidase. WO 01/60399 Patent (2001).

  50. S. Joseph and W. Stuart. Penetration enhancement of topically applied formulations. EP 539215 Patent (1993).

  51. S. L. Hargrave J. C. Junng M. E. Fini H. Gelender C. Cather A. Guidera I. Udell S. Fischer J. V. Jester R. W. Bowman J. P. McCulley H. D. Cavanagh (2002) ArticleTitlePossible role of the vitamin E solubilizer in topical diclofenac on matrix metalloproteinase expression in corneal metling: an analysis of postoperative keratolysis Ophtalmology 109 343–350

    Google Scholar 

  52. M. J. Alonso (2004) ArticleTitleNanomedicines for overcoming biological barriers Biomed. Pharmacother. 58 168–172 Occurrence Handle15082339

    PubMed  Google Scholar 

  53. J. M. Odeberg P. Kaufmann K. G. Kroon P. Hoglund (2003) ArticleTitleLipid drug delivery and rational formulation design for lipophilic drugs with low oral bioavailability, applied to Cyclosporine Eur. J. Pharm. Sci. 20 375–382 Occurrence Handle1:CAS:528:DC%2BD3sXptlynuro%3D Occurrence Handle14659481

    CAS  PubMed  Google Scholar 

  54. J. M. Dintman J. A. Silverman (1999) ArticleTitleInhibition of P-glycoprotein by d-alpha-tocopheryl polyethylene glycol 1000 succinate (TPGS) Pharm. Res. 16 1550–1556

    Google Scholar 

  55. G. Cornaire J. Woodley P. Hermann A. Cloarec C. Arellano G. Houin (2004) ArticleTitleImpact of excipients on the absorption of P-glycoprotein substrates in vitro and in vivo Int. J. Pharm. 278 119–131 Occurrence Handle10.1016/j.ijpharm.2004.03.001 Occurrence Handle1:CAS:528:DC%2BD2cXktFOiur4%3D Occurrence Handle15158955

    Article  CAS  PubMed  Google Scholar 

  56. R. J. Sokol K. E. Johnson F. M. Karrer (1991) ArticleTitleImprovement of cyclosporine absorption in children after liver transplantation by means of water-soluble vitamin E Lancet 338 211–215 Occurrence Handle10.1016/0140-6736(91)90349-T

    Article  Google Scholar 

  57. S. H. Pan R. R. Lopez L. S. Sher A. L. Hoffman L. G. Podesta L. Makowka P. Rosenthal (1996) ArticleTitleEnhanced oral cyclosporine absorption with water-soluble vitamin E early after liver transplantation Pharmacotherapy 16 59–65 Occurrence Handle1:STN:280:BymB1cnjtF0%3D Occurrence Handle8700793

    CAS  PubMed  Google Scholar 

  58. J. P. Boudreaux D. H. Hayes S. Mizrahi P. Maggiore J. Blazek D. Dick (1993) ArticleTitleUse of water-soluble liquid vitamin E to enhance cyclosporine absorption in children after liver transplant Transplant. Proc. 25 1875 Occurrence Handle1:STN:280:ByyB38jjs1M%3D Occurrence Handle8470210

    CAS  PubMed  Google Scholar 

  59. T. Chang L. Z. Benet M. F. Herbert (1996) ArticleTitleThe effect of water-soluble vitamin e on cyclosporine pharmacokinetics in healthy volunteers Clin. Pharmacol. Ther. 59 297–303 Occurrence Handle1:CAS:528:DyaK28**sFynu7s%3D Occurrence Handle8653992

    CAS  PubMed  Google Scholar 

  60. G. J. Sebastian, L. Gregory, R. Alain, and S. Benita. Self-nanoemulsifying oily formulations for the administration of poorly water-soluble drugs. EP1510206 Patent (2005).

  61. S. Yang R. N. Gursoy G. Lambert S. Benita (2004) ArticleTitleEnhanced oral absorption of paclitaxel in a novel self-microemulsifying drug delivery system with or without concomitant use of P-glycoprotein inhibitors Pharm. Res. 21 261–270 Occurrence Handle1:CAS:528:DC%2BD2cXhtlWqt70%3D Occurrence Handle15032307

    CAS  PubMed  Google Scholar 

  62. M. V. S. Varma R. Panchagnula (2005) ArticleTitleEnhanced oral paclitaxel absorption with vitamin E-TPGS: effect of solubility and permeability in vitro, in situ and in vivo Eur. J. Pharm. Sci. 25 445–453 Occurrence Handle1:CAS:528:DC%2BD2MXlsVCltbg%3D Occurrence Handle15890503

    CAS  PubMed  Google Scholar 

  63. L. Yu A. Bridgers J. Polli A. Vickers A. Roy R. Winnike M. Coffin (1999) ArticleTitleVitamin E-TPGS increases absorption flux of an HIV protease inhibitor by enhancing its solubility and permeability Pharm. Res. 16 1812–1817 Occurrence Handle1:CAS:528:DC%2BD3cXkt1egsQ%3D%3D Occurrence Handle10644067

    CAS  PubMed  Google Scholar 

  64. M. M. Malingre J. H. Beinjen J. H. M. Schellens (2001) ArticleTitleOral delivery of taxanes Invest. New Drugs 19 155–162 Occurrence Handle1:CAS:528:DC%2BD3MXktF2qurk%3D Occurrence Handle11392449

    CAS  PubMed  Google Scholar 

  65. L. Zuylen Particlevan J. Verweij A. Sparreboom (2001) ArticleTitleRole of formulation vehicles in taxane pharmacology Invest. New Drugs 19 125–141 Occurrence Handle11392447

    PubMed  Google Scholar 

  66. J. H. M Schellens M. M. Malingre C. M. F. Kruijtzer H. A. Bardelmeijer O. Tellingen ParticleVan A. H. Schinkel J. H. Beijnen (2000) ArticleTitleModulation of oral bioavailability of anticancer drugs: from mouse to man Eur. J. Pharm. Sci. 12 103–110 Occurrence Handle1:CAS:528:DC%2BD3cXotlGjsLg%3D Occurrence Handle11102737

    CAS  PubMed  Google Scholar 

  67. P. Gao B. D. Rush W. P. Pfund T. Huang J. M. Bauer W. Morozowich M. S. Kuo M. J. Hageman (2003) ArticleTitleDevelopment of a supersaturable SEDDS (S-SEDDS) formulation of paclitaxel with improved oral bioavailability J. Pharm. Sci. 92 2386–2398 Occurrence Handle10.1002/jps.10511 Occurrence Handle1:CAS:528:DC%2BD3sXps1OisLY%3D Occurrence Handle14603484

    Article  CAS  PubMed  Google Scholar 

  68. J. Alsenz H. Steffen R. Alex (1998) ArticleTitleActive apical secretory efflux of the HIV protease inhibitors saquinavir and ritonavir in Caco-2 cell monolayers Pharm. Res. 15 423–428 Occurrence Handle10.1023/A:1011924314899 Occurrence Handle1:CAS:528:DyaK1c**sVGru7Y%3D Occurrence Handle9563072

    Article  CAS  PubMed  Google Scholar 

  69. R. G. Stricley (2004) ArticleTitleSolubilizing excipients in oral and injectable formulations Pharm. Res. 21 201–230

    Google Scholar 

  70. K. Ramsay-Olocco L. Alexandrova R. Nellore R. Killion L. Li P. Coen Q. Ho D. Jung C. Rocha (2004) ArticleTitlePreclinical and clinical evaluation of solution and soft gelatin capsule formulations for BCS class 3 compound with atypical physicochemical properties J. Pharm. Sci. 93 2214–2221 Occurrence Handle10.1002/jps.20127 Occurrence Handle1:CAS:528:DC%2BD2cXnsVegur0%3D Occurrence Handle15295782

    Article  CAS  PubMed  Google Scholar 

  71. G. L. Amidon H. Lennernas V. P. Shah J. R. Crison (1995) ArticleTitleA theoretical basis for a biopharmaceutic drug classification: the correlation of in vitro drug product dissolution and in vivo bioavailability Pharm. Res. 12 413–420 Occurrence Handle1:CAS:528:DyaK2MXksVGqur8%3D Occurrence Handle7617530

    CAS  PubMed  Google Scholar 

  72. W.-T. Ke S.-Y. Lin H.-O. Ho M.-T. Sheu (2005) ArticleTitlePhysical characterization of microemulsion systems using tocopheryl-polyethylene glycol 1000-succinate (TPGS) as a surfactant for the oral delivery of protein drugs J. Control. Release 102 489–507 Occurrence Handle10.1016/j.jconrel.2004.10.030 Occurrence Handle1:CAS:528:DC%2BD2MXktVCqtA%3D%3D Occurrence Handle15653166

    Article  CAS  PubMed  Google Scholar 

  73. W. J. Martone W. W. Williams M. L. Mortensen R. P. Gaynes J. W. White V. Lorch M. D. Murphy S. N. Sinha D. J. Frank N. Kosmetatos C. J. Bodenstein R. J. Roberts (1986) ArticleTitleIllness with fatalities in premature infants: association with an intravenous vitamin E preparation, E-ferol Paediatrica 78 591–600 Occurrence Handle1:STN:280:BiiD3Mngs1A%3D

    CAS  Google Scholar 

  74. J. B. Arrowsmith G. A. Faich D. K. Tomita J. N. Kuritsky F. W. Rosa (1989) ArticleTitleMorbidity and mortality among low birth-weight infants exposed to an intravenous vitamin E product, E-ferol Paediatrica 83 244–249 Occurrence Handle1:STN:280:BiaC3M3pt1A%3D

    CAS  Google Scholar 

  75. S. L. Alade R. E. Brown A. Paquet (1986) ArticleTitlePolysorbate 80 and E-ferol toxicity Paediatrica 77 593–597 Occurrence Handle1:STN:280:BimC2snltVU%3D

    CAS  Google Scholar 

  76. H. Kunieda O. Kei-Ichi (1990) ArticleTitleThree-phase behavior and HLB numbers of bile salts and lecithin in a water–oil system J. Colloid Interface Sci. 136 432–439 Occurrence Handle10.1016/0021-9797(90)90390-A Occurrence Handle1:CAS:528:DyaK3c**tVGgsb4%3D

    Article  CAS  Google Scholar 

  77. S. Benita M. Y. Levy (1993) ArticleTitleSubmicron emulsions as colloidal drug carriers for intravenous administration: comprehensive physicochemical characterization J. Pharm. Sci. 82 1069–1079 Occurrence Handle1:CAS:528:DyaK2cXhsVOjuw%3D%3D Occurrence Handle8289116

    CAS  PubMed  Google Scholar 

  78. J. Han C. Washington C. Papandreou S. S. Davis (2004) ArticleTitleDesign and evaluation of an emulsion vehicle for paclitaxel. I. Physicochemical properties and plasma stability Pharm. Res. 21 1573–1580 Occurrence Handle10.1023/B:PHAM.0000041451.70367.21 Occurrence Handle1:CAS:528:DC%2BD2cXnsFyjsLk%3D Occurrence Handle15497682

    Article  CAS  PubMed  Google Scholar 

  79. A. N. Lukyanov W. C. Hartner V. P. Torchilin (2004) ArticleTitleIncreased accumulation of PEG-PE micelles in the area of experimental myocardial infarction in rabbits J. Control. Release 94 187–193 Occurrence Handle10.1016/j.jconrel.2003.10.008 Occurrence Handle1:CAS:528:DC%2BD3sXpslClsb8%3D Occurrence Handle14684282

    Article  CAS  PubMed  Google Scholar 

  80. M. C. Woodle (1998) ArticleTitleControlling liposome blood clearance by surface-grafted polymers Adv. Drug Deliv. Rev. 32 139–152 Occurrence Handle10.1016/S0169-409X(97)00136-1 Occurrence Handle1:CAS:528:DyaK1c**vVCmtr0%3D Occurrence Handle10837640

    Article  CAS  PubMed  Google Scholar 

  81. L. Mu S. S. Feng (2002) ArticleTitleVitamin E TPGS used as emulsifier in the solvent evaporation/extraction technique for fabrication of polymeric nanospheres for controlled release of paclitaxel (Taxol) J. Control. Release 80 129–144 Occurrence Handle10.1016/S0168-3659(02)00025-1 Occurrence Handle1:CAS:528:DC%2BD38**sFyrsLo%3D Occurrence Handle11943393

    Article  CAS  PubMed  Google Scholar 

  82. P. P. Constantinides K. J. Lambert A. K. Tustian B. Schneider S. Lalji W. W. Ma B. Wentzel D. Kessler D. Worah S. C. Quay (2000) ArticleTitleFormulation development and antitumour activity of a filter-sterilizable emulsion of paclitaxel Pharm. Res. 17 175–182 Occurrence Handle10.1023/A:1007565230130 Occurrence Handle1:CAS:528:DC%2BD3c**tVOqur8%3D Occurrence Handle10751032

    Article  CAS  PubMed  Google Scholar 

  83. W. Lin M. C. Garnett E. Schacht S. S. Davis L. Illum (1999) ArticleTitlePreparation and in vitro characterization of HSA-mPEG nanoparticles Int. J. Pharm. 189 161–170 Occurrence Handle10.1016/S0378-5173(99)00253-7 Occurrence Handle1:CAS:528:DyaK1MXmvVaqtLc%3D Occurrence Handle10536244

    Article  CAS  PubMed  Google Scholar 

  84. K. L. Prime G. M. Whitesides (1993) ArticleTitleAdsorption of proteins onto surfaces containing end-attached oligo(ethylene oxide): a model system using self-assembled monolayers J. Am. Chem. Soc. 115 10714–10721 Occurrence Handle10.1021/ja00076a032 Occurrence Handle1:CAS:528:DyaK3sXmsVCrtbk%3D

    Article  CAS  Google Scholar 

  85. J. Plowman D. J. Dykes M. Hollingshead L. Simpson-Herren M. C. Alley (1997) Human tumor xenograft models in NCI development B. A. Teicher (Eds) Anticancer Drug Development Guide: Preclinical Screening, Clinical Trials and Approval Human Press Totowa, NJ 101–125

    Google Scholar 

  86. J. Wang Y. Maitani K. Tadayama (2002) ArticleTitleAntitumor effects and pharmacokinetics of aclacinomycin A carried by injectable emulsions composed of vitamin E cholesterol and PEG-lipid J. Pharm. Sci. 91 1128–1134 Occurrence Handle1:CAS:528:DC%2BD38XjtFKhu7g%3D Occurrence Handle11948551

    CAS  PubMed  Google Scholar 

  87. J. Wang K. Yakayama T. Nagai Y. Maitani (2003) ArticleTitlePharmacokinetics and antitumor effects of vincristine carried by microemulsions composed of PEG-lipid, oleic acid, vitamin E and cholesterol Int. J. Pharm. 251 13–21 Occurrence Handle1:CAS:528:DC%2BD3s**s1Whsw%3D%3D

    CAS  Google Scholar 

  88. M. R. Sonne. Tocopherol compositions for delivery of biologically active agents, USPTO Patent Full-Text and Image Database No. 6,193,985, Dumex Ltd, Copenhagen, DK, United States (2001), pp. 1–21

  89. D. Liu L. Huang (1989) ArticleTitleSmall, but not large, unilamellar liposomes composed of dioleoylphosphatidylethanolamine and oleic-acid can be stabilized by human plasma Biochemistry 28 7700–7707 Occurrence Handle1:CAS:528:DyaL1MXlsVSgs7w%3D Occurrence Handle2611208

    CAS  PubMed  Google Scholar 

  90. H. Jizomoto E. Kanaoka K. Hirano (1994) ArticleTitlepH-sensitive liposomes conposed of tocopherol hemisuccinate and of phosphatidylethanolamine including tocopherol hemisuccinate Biochim. Biophys. Acta, Lipids Lipid. Metab. 1213 343–348 Occurrence Handle1:CAS:528:DyaK2cXls1eqs70%3D

    CAS  Google Scholar 

  91. M. T. Sheu S. Y. Chen L. C. Chen H. O. Ho (2003) ArticleTitleInfluence of micelle solubilization by tocopheryl polyethylene glycol succinate (TPGS) on solubility enhancement and percutaneous penetration of estradiol J. Control. Release 88 355–368 Occurrence Handle10.1016/S0168-3659(02)00492-3 Occurrence Handle1:CAS:528:DC%2BD3s**tVGhsL0%3D Occurrence Handle12644362

    Article  CAS  PubMed  Google Scholar 

  92. G. Ismailos C. Reppas P. Macheras (1994) ArticleTitleEnhancement of cyclosporin A solubility by d-alpha tocopheryl-polyethylene-glycol 1000 succinate Eur. J. Pharm. Sci. 1 269–271 Occurrence Handle1:CAS:528:DyaK2cXkvFWnurg%3D

    CAS  Google Scholar 

  93. J. Quin D. Engles A. Litwiller E. Peralta A. Grasch T. Boley S. Hazelrigg (2005) ArticleTitleVitamin E succinate decreases lung cancer tumor growth in mice J. Surg. Res. 127 139–143 Occurrence Handle10.1016/j.jss.2005.01.014 Occurrence Handle1:CAS:528:DC%2BD2MXntVGmtbw%3D Occurrence Handle16083751

    Article  CAS  PubMed  Google Scholar 

  94. H.-J. Youk E. Lee M.-K. Choi Y.-J. Lee J. H. Chung S.-H. Kim C.-H. Lee S.-J. Lim (2005) ArticleTitleEnhanced anticancer efficacy of α-tocopheryl succinate by conjugation with polyethylene glycol J. Control. Release 107 43–52 Occurrence Handle10.1016/j.jconrel.2005.05.014 Occurrence Handle1:CAS:528:DC%2BD2MXpvVSnsrk%3D Occurrence Handle16081183

    Article  CAS  PubMed  Google Scholar 

  95. M. Bartels H. K. Biesatski K. Engelhart G. Sendlhofer P. Rehak E. Nagel (2004) ArticleTitlePilot study on the effect of parenteral vitamin E on ischemia and reperfusion induced liver injury: a double blind, randomized, placebo-controlled trial Clin. Nutr. 23 1360–1370 Occurrence Handle1:CAS:528:DC%2BD2cXhtVSlu7jJ Occurrence Handle15556258

    CAS  PubMed  Google Scholar 

  96. P. Fuentes P. D. Cooper R. Barnadas M. Sabes C. Osterhoff P. Martinez (2003) ArticleTitleUse of γ-inulin/liposomes/vitamin E adjuvant combination in contraceptive vaccines Int. J. Pharm. 257 85–95 Occurrence Handle10.1016/S0378-5173(03)00127-3 Occurrence Handle1:CAS:528:DC%2BD3sXjtVemsrw%3D Occurrence Handle12711164

    Article  CAS  PubMed  Google Scholar 

  97. B. M. Hybertson J. A. Leff C. J. Beehler P. C. Barry (1995) ArticleTitleEffect of vitamin E deficiency and supercritical fluid aerosolized vitamin E supplementation on interleukin-1-induced oxidative lung injury in rats Free Radic. Biol. Med. 18 537–542 Occurrence Handle10.1016/0891-5849(94)00180-R Occurrence Handle1:CAS:528:DyaK2MXjsFygsr4%3D Occurrence Handle9101244

    Article  CAS  PubMed  Google Scholar 

  98. Z. Suntres P. Shek (1995) ArticleTitleLiposomal α-tocopherol alleviates the progression of paraquat-induced lung damage J. Drug Target. 2 493–500 Occurrence Handle1:CAS:528:DyaK2MXjvVCnsbc%3D Occurrence Handle7773611

    CAS  PubMed  Google Scholar 

  99. S. Somavarapu S. Pandit G. Gradassi M. Bandera E. Ravichandran O. H. Alpar (2005) ArticleTitleEffect of vitamin E-TPGS on immune response to nasally delivered diphtheria toxoid loaded poly(caprolactone) microparticles Int. J. Pharm. 298 344–347 Occurrence Handle10.1016/j.ijpharm.2005.03.029 Occurrence Handle1:CAS:528:DC%2BD2MXlvV2nu7o%3D Occurrence Handle15967606

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgments

We would like to thank Professor Simon Benita of Hebrew University, School of Pharmacy, Jerusalem, Israel, and Dr. Lawrence Yu of the Food and Drug Administration Agency, CDER, Rockville, MD, for permission to include some of their published work in this review article. We are grateful to Dr. Andreas M. Papas of Yasoo Health Inc., Johnson City, TN, for providing the structures of tocopherols and tocotrienols and useful discussions on the function and metabolism of these molecules.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Panayiotis P. Constantinides.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Constantinides, P.P., Han, J. & Davis, S.S. Advances in the Use of Tocols as Drug Delivery Vehicles. Pharm Res 23, 243–255 (2006). https://doi.org/10.1007/s11095-005-9262-9

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11095-005-9262-9

Key Words

Navigation